Page last updated: 2024-10-26

disulfiram and Ototoxicity

disulfiram has been researched along with Ototoxicity in 1 studies

Ototoxicity: Damage to the EAR or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freyer, DR1
Brock, P1
Knight, K1
Reaman, G1
Cabral, S1
Robinson, PD1
Sung, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 3 Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy Incorporating a Randomized Assessment of Sodium Thiosulfate as Otoprotection for Children With Localized Disease, and Respons[NCT04478292]Phase 3330 participants (Anticipated)Interventional2021-03-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for disulfiram and Ototoxicity

ArticleYear
Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
    The Lancet. Child & adolescent health, 2019, Volume: 3, Issue:8

    Topics: Acetylcysteine; Adolescent; Amifostine; Anti-Inflammatory Agents; Antineoplastic Agents; Chelating A

2019